Eagle Pharmaceuticals (EGRX)

$1.65 -0.15 (-8.33%)
Market Cap 23.38M
Revenue (ttm) 316.61M
Net Income (ttm) 35.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 11.26%
Debt to Equity Ratio 0.28
Volume 501
Avg Vol 7,928
Day's Range N/A - N/A
Shares Out 12.99M
Stochastic %K 82%
Beta 0.83
Analysts Strong Buy
Price Target $17.00

Latest News on EGRX

No data available.